COMMD3

COMMD3 is a multifunctional adaptor protein that operates in receptor signaling and endosomal membrane trafficking (PMID:31088898, PMID:40838988). As an obligate partner in the COMMD3/8 heterocomplex, it functions as a specificity adaptor that selectively recruits GRK6 to activated chemoattractant receptors such as CXCR4, driving receptor phosphorylation and β-arrestin-mediated signaling required for B cell migration and humoral immune responses; COMMD8 stability is itself dependent on COMMD3 (PMID:31088898). This complex is the direct covalent target of celastrol, whose immunosuppressive action depends on dissociating COMMD3/8 (PMID:37000855). COMMD3 is also a subunit of the broader COMMD/CCDC22/CCDC93 (CCC) complex that directs membrane cargo through endosomal recycling pathways, controlling trafficking of cargo including HER2 into a slow recycling route and of P-selectin away from lysosomal degradation in megakaryocyte α-granule biogenesis (PMID:34905616, PMID:36445330). Beyond the Commander complex, the COMMD3 N-terminal domain independently binds and stabilizes the small GTPase ARF1 to recycle a distinct subset of cargo proteins unaffected by loss of other Commander subunits (PMID:40838988). COMMD3 additionally modulates membrane protein abundance more broadly, downregulating epithelial sodium channel (ENaC) surface expression independently of COMMD1 (PMID:23637203). A recurrent theme across cancer models links COMMD3 to intracellular copper homeostasis and copper-dependent enzyme activity (PMID:37072858, PMID:42150995).

1. 1992 Low

   Before any function was known, the gene now called COMMD3 had to be cloned and placed in the genome; this established its existence as a distinct locus encoding a novel protein.

   Evidence cDNA cloning and genomic sequencing of the BUP locus upstream of bmi-1 in mouse

   PMID:1287475

   Open questions at the time

   • No functional or mechanistic role assigned
   • No conserved motifs or homology identifiable at the time
   • Protein product uncharacterized
2. 2013 Medium

   The first mechanistic role addressed whether COMMD3 regulates membrane transporter surface levels, showing it can downregulate ENaC independently of COMMD1.

   Evidence Co-IP, surface biotinylation, and amiloride-sensitive current electrophysiology with COMMD1 knockdown in epithelial cells

   PMID:23637203

   Open questions at the time

   • Mechanism of ENaC surface reduction not resolved
   • Not independently replicated
   • Relationship to later-defined CCC/recycling role unaddressed
3. 2019 High

   A defining function emerged with the discovery that COMMD3/8 acts as a specificity adaptor recruiting GRK6 to chemoattractant receptors, establishing a direct role in GPCR signaling and lymphocyte chemotaxis.

   Evidence Reciprocal Co-IP, genetic knockout, receptor phosphorylation assays, and in vivo B cell migration and humoral response assays

   PMID:31088898

   Open questions at the time

   • Structural basis of GRK6 selectivity not defined
   • Range of receptors served by COMMD3/8 not fully mapped
   • Connection to broader Commander/CCC role unclear
4. 2019 Low

   A separate line tested whether COMMD3 acts in transcriptional control of oncogenes, reporting recruitment to the C-MYC promoter in prostate cancer cells.

   Evidence ChIP, siRNA knockdown, expression analysis, and xenograft model

   PMID:31467179

   Open questions at the time

   • Single method per claim with no independent replication
   • Direct vs indirect promoter occupancy not distinguished
   • Hard to reconcile with cytoplasmic/endosomal roles
5. 2022 Medium

   COMMD3 was placed within the CCC complex in megakaryocytes, linking it to cargo trafficking and organelle biogenesis by showing it protects P-selectin and PF4 from lysosomal degradation during α-granule formation.

   Evidence Co-IP, shRNA knockdown, flow cytometry, immunofluorescence, and TEM of α-granules

   PMID:34905616

   Open questions at the time

   • Single lab, not independently replicated
   • Direct cargo-binding mechanism not established
   • Scope of affected cargoes beyond P-selectin/PF4 unclear
6. 2023 Medium

   The Commander/CCC trafficking role was extended to cancer-relevant cargo, identifying COMMD3 as directing HER2 into a slow recycling pathway to attenuate tumor-promoting signaling.

   Evidence Genome-wide CRISPR screen, Co-IP, transcriptome analysis, and orthotopic mouse model in ovarian carcinoma

   PMID:36445330

   Open questions at the time

   • Direct vs complex-mediated HER2 binding not separated
   • Single lab
   • Generality of slow-recycling routing across cargoes unknown
7. 2023 High

   The pharmacology of COMMD3/8 was defined by showing celastrol covalently binds and dissociates the complex, with a resistant mutant conferring protection in vivo, confirming COMMD3/8 as celastrol's direct target.

   Evidence Covalent binding biochemistry, celastrol-resistant knock-in mice, B cell migration assays, and in vivo arthritis model

   PMID:37000855

   Open questions at the time

   • Precise covalent residue/site not detailed here
   • Downstream signaling consequences beyond migration not fully mapped
8. 2023 Medium

   A copper-homeostasis link was proposed, with COMMD3 loss promoting invasive breast cancer growth via regulation of the Na+/K+-ATPase subunit ATP1B1 and copper signaling.

   Evidence shRNA knockdown, 3D assay, RNA-seq, copper chelation rescue, and syngeneic mouse model

   PMID:37072858

   Open questions at the time

   • No direct biochemical interaction with copper machinery shown
   • Single lab
   • Causal chain from ATP1B1 to copper to invasion inferred
9. 2025 High

   A Commander complex-independent activity was defined: the COMMD3 N-terminal domain directly binds and stabilizes ARF1 to recycle a subset of cargo not served by other Commander subunits, distinguishing two separable trafficking functions.

   Evidence Unbiased genetic screens, comparative targeted mutagenesis, direct binding assays, and cargo recycling assays

   PMID:39763841 PMID:40838988

   Open questions at the time

   • Identity of the ARF1-dependent cargo subset not fully enumerated
   • Structural detail of the NTD–ARF1 interface limited
   • How the two COMMD3 trafficking modes are coordinated unknown
10. 2025 Low

    The copper axis was extended to multiple myeloma, placing COMMD3 upstream of ATOX1 in an ATOX1-ATP7A-LOX copper-metabolism pathway.

    Evidence Lentiviral over/knockdown, RNA-seq, intracellular copper measurement, ATOX1 inhibition rescue, and xenograft model

    PMID:40002764

    Open questions at the time

    • Epistasis inferred from inhibitor rescue without direct COMMD3–ATOX1 interaction
    • Single lab
    • Mechanism of copper level control unresolved
11. 2026 Low

    A pigmentation role was reported, with COMMD3 controlling intracellular copper to modulate tyrosinase activity and acting via a CLU-PAX3 axis to promote melanogenesis.

    Evidence Knockdown in B16F10 cells, RNA-seq, copper measurement, chelation rescue, and UVB pigmentation mouse model

    PMID:42150995

    Open questions at the time

    • Pathway placement based on indirect evidence
    • No direct biochemical interaction with copper transporters or CLU shown
    • Single lab

• How COMMD3's distinct activities—GRK6/β-arrestin adaptation, CCC-dependent and ARF1-dependent recycling, and copper homeostasis—are mechanistically integrated within one protein remains unresolved.
• No structural model unifying COMMD3 domains across functions
• Whether copper regulation is direct or a downstream trafficking consequence is unknown
• Cross-talk between Commander-dependent and -independent recycling not defined